Low-cost anti-mycobacterial drug discovery using engineered E. coli.
Bongaerts N, Edoo Z, Abukar AA, Song X, Sosa-Carrillo S, Haggenmueller S, Savigny J, Gontier S, Lindner AB, Wintermute EH.
Bongaerts N, et al. Among authors: abukar aa.
Nat Commun. 2022 Jul 7;13(1):3905. doi: 10.1038/s41467-022-31570-3.
Nat Commun. 2022.
PMID: 35798732
Free PMC article.